{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:01:47Z","timestamp":1762506107687},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2013,5,27]],"date-time":"2013-05-27T00:00:00Z","timestamp":1369612800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0064283","type":"journal-article","created":{"date-parts":[[2013,5,27]],"date-time":"2013-05-27T20:14:49Z","timestamp":1369685689000},"page":"e64283","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Hyaluronic Acid Levels Predict Risk of Hepatic Encephalopathy and Liver-Related Death in HIV\/Viral Hepatitis Coinfected Patients"],"prefix":"10.1371","volume":"8","author":[{"given":"Lars","family":"Peters","sequence":"first","affiliation":[]},{"given":"Amanda","family":"Mocroft","sequence":"additional","affiliation":[]},{"given":"Vincent","family":"Soriano","sequence":"additional","affiliation":[]},{"given":"J\u00fcrgen","family":"Rockstroh","sequence":"additional","affiliation":[]},{"given":"Andri","family":"Rauch","sequence":"additional","affiliation":[]},{"given":"Anders","family":"Karlsson","sequence":"additional","affiliation":[]},{"given":"Brygida","family":"Knysz","sequence":"additional","affiliation":[]},{"given":"Christian","family":"Pradier","sequence":"additional","affiliation":[]},{"given":"Kai","family":"Zilmer","sequence":"additional","affiliation":[]},{"given":"Jens D.","family":"Lundgren","sequence":"additional","affiliation":[]},{"name":"for EuroSIDA in EuroCoord","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2013,5,27]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1053\/j.gastro.2008.02.069","article-title":"Disease progression in chronic hepatitis C: modifiable and nonmodifiable factors","volume":"134(6)","author":"SB Missiha","year":"2008","journal-title":"Gastroenterology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/hep.510300409","article-title":"Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group","volume":"30(4)","author":"Y Benhamou","year":"1999","journal-title":"Hepatology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(02)11913-1","article-title":"HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)","volume":"360(9349)","author":"CL Thio","year":"2002","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1478-3231.2008.01691.x","article-title":"Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies","volume":"28(5)","author":"RP Myers","year":"2008","journal-title":"Liver Int"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/hep.20535","article-title":"Sources of variability in histological scoring of chronic viral hepatitis","volume":"41(2)","author":"MC Rousselet","year":"2005","journal-title":"Hepatology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1310\/hct1001-25","article-title":"Rates of HCV treatment eligibility among HCV-monoinfected and HCV\/HIV-coinfected patients in tertiary care referral centers","volume":"10(1)","author":"AA Butt","year":"2009","journal-title":"HIV Clin Trials"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1365-2893.2006.00740.x","article-title":"Treatment of hepatitis C virus and human immunodeficiency virus coinfection: from large trials to real life","volume":"13(10)","author":"P Cacoub","year":"2006","journal-title":"J Viral Hepat"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cld.2008.07.010","article-title":"Noninvasive assessment of liver fibrosis: serum markers, imaging, and other modalities","volume":"12(4)","author":"IN Guha","year":"2008","journal-title":"Clin Liver Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jhep.2008.07.039","article-title":"Exceeding the limits of liver histology markers","volume":"50(1)","author":"SH Mehta","year":"2009","journal-title":"J Hepatol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0014-4827(83)90458-5","article-title":"Endothelial cells are a site of uptake and degradation of hyaluronic acid in the liver","volume":"144(1)","author":"S Eriksson","year":"1983","journal-title":"Exp Cell Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1476-5926-4-6","article-title":"Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus","volume":"4","author":"P Halfon","year":"2005","journal-title":"Comp Hepatol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1046\/j.1365-2893.1998.00100.x","article-title":"Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection","volume":"5(3)","author":"VS Wong","year":"1998","journal-title":"J Viral Hepat"},{"key":"ref13","first-page":"789","article-title":"Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C. Hepatology","volume":"47(3)","author":"RJ Fontana","year":"2008"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/01.qai.0000184856.31695.bf","article-title":"HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease","volume":"40(5)","author":"D Nunes","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref15","first-page":"1401","article-title":"Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C. Gut","volume":"59(10)","author":"RJ Fontana","year":"2010"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0168-8278(00)80396-7","article-title":"Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis","volume":"32(3)","author":"J Guechot","year":"2000","journal-title":"J Hepatol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2893.2009.01103.x","article-title":"Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection","volume":"16(7)","author":"A Sanvisens","year":"2009","journal-title":"J Viral Hepat"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/1471-2334-10-244","article-title":"Can serum hyaluronic acid replace simple non-invasive indexes to predict liver fibrosis in HIV\/Hepatitis C coinfected patients?","volume":"10","author":"S Resino","year":"2010","journal-title":"BMC Infect Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0140-6736(03)13802-0","article-title":"Decline in the AIDS and death rates in the EuroSIDA study: an observational study","volume":"362(9377)","author":"A Mocroft","year":"2003","journal-title":"Lancet"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.aids.0000163936.99401.fe","article-title":"Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort","volume":"19(6)","author":"D Konopnicki","year":"2005","journal-title":"AIDS"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1086\/432762","article-title":"Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy","volume":"192(6)","author":"JK Rockstroh","year":"2005","journal-title":"J Infect Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1086\/592171","article-title":"Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe","volume":"198(9)","author":"V Soriano","year":"2008","journal-title":"J Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1310\/hct1202-109","article-title":"A standardized algorithm for determining the underlying cause of death in HIV infection as AIDS or non-AIDS related: results from the EuroSIDA study","volume":"12(2)","author":"JD Kowalska","year":"2011","journal-title":"HIV Clin Trials"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1053\/jhep.2002.31250","article-title":"Hepatic encephalopathy\u2013definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998","volume":"35(3)","author":"P Ferenci","year":"2002","journal-title":"Hepatology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60(8)","author":"RN Pugh","year":"1973","journal-title":"Br J Surg"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1053\/he.2000.5852","article-title":"A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts","volume":"31(4)","author":"M Malinchoc","year":"2000","journal-title":"Hepatology"},{"key":"ref27","first-page":"1887","article-title":"A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C. Clin Chem","volume":"52(10)","author":"Y Ngo","year":"2006"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1136\/gut.2009.203166","article-title":"Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease","volume":"59(9)","author":"J Parkes","year":"2010","journal-title":"Gut"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/ajg.2009.746","article-title":"Noninvasive Markers of Liver Fibrosis Are Highly Predictive of Liver-Related Death in a Cohort of HCV-Infected Individuals With and Without HIV Infection","volume":"105(6)","author":"D Nunes","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jhep.2005.02.025","article-title":"Prediction of hepatic fibrosis in HIV\/HCV co-infected patients using serum fibrosis markers: the SHASTA index","volume":"43(1)","author":"TB Kelleher","year":"2005","journal-title":"J Hepatol"},{"key":"ref31","first-page":"667","article-title":"Hyaluronic acid levels predict increased risk of non-AIDS death in hepatitis-coinfected persons interrupting antiretroviral therapy in the SMART Study","volume":"16(5)","author":"L Peters","year":"2011","journal-title":"Antivir Ther"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/01.qai.0000184856.31695.bf","article-title":"HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease","volume":"40(5)","author":"D Nunes","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/COH.0b013e328329c602","article-title":"Liver disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation","volume":"4(3)","author":"M Vogel","year":"2009","journal-title":"Curr Opin HIV AIDS"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/art.1780301203","article-title":"Circulating hyaluronic acid levels vary with physical activity in healthy subjects and in rheumatoid arthritis patients. Relationship to synovitis mass and morning stiffness","volume":"30(12)","author":"A Engstrom-Laurent","year":"1987","journal-title":"Arthritis Rheum"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/j.1440-1746.1998.tb00608.x","article-title":"Effects of eating on plasma hyaluronan in patients with cirrhosis: its mechanism and influence on clinical interpretation","volume":"13(12)","author":"CS Wong","year":"1998","journal-title":"J Gastroenterol Hepatol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"568","DOI":"10.2169\/internalmedicine.37.568","article-title":"Post-prandial serum hyaluronan concentration in patients with chronic liver disease","volume":"37(7)","author":"Y Idobe","year":"1998","journal-title":"Intern Med"},{"key":"ref37","unstructured":"Baker J, Tracy R, for the INSIGHT SMART Study Group (2011) Pro- and Anti-coagulant Activity Among HIV-infected Patients in the Strategies for Management of Anti-Retroviral Therapy (SMART) Trial: Randomized comparisons of stopping and starting antiretroviral therapy. Abstract 811 at the 18<sup>th<\/sup> Conference on Retroviruses and Opportunistic Infection"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1371\/journal.pmed.0050203","article-title":"Inflammatory and coagulation biomarkers and mortality in patients with HIV infection","volume":"5(10)","author":"LH Kuller","year":"2008","journal-title":"PLoS Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/hep.23716","article-title":"Clinical syndromes and consequences of antiretroviral-related hepatotoxicity","volume":"52(3)","author":"M Nunez","year":"2010","journal-title":"Hepatology"},{"key":"ref40","first-page":"59","article-title":"Platelet count kinetics following Interruption of antiretroviral treatment: Results from the SMART study","volume":"27(1)","author":"E Zetterberg","year":"2012","journal-title":"AIDS"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1093\/infdis\/jir134","article-title":"Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death","volume":"203(11)","author":"DR Boulware","year":"2011","journal-title":"J Infect Dis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0064283","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,14]],"date-time":"2019-07-14T05:12:08Z","timestamp":1563081128000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0064283"}},"subtitle":[],"editor":[{"given":"Jason","family":"Blackard","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2013,5,27]]},"references-count":41,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,5,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0064283","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2013,5,27]]}}}